Press release
RNA Based Therapeutic Market Update 2023: Projected to Cross Market Value of USD 25.12 Billion by 2030
Key Takeaways:
Growing Market: The RNA-based therapeutics market has experienced significant growth in recent years and is expected to continue expanding. Advances in RNA technology, particularly in the field of RNA interference (RNAi) and messenger RNA (mRNA), have fueled this growth.
RNA Interference (RNAi): RNAi is a process by which small interfering RNA (siRNA) molecules can target and silence specific genes, inhibiting the production of disease-causing proteins. RNAi-based therapeutics have shown promise in treating various diseases, including cancer, genetic disorders, and viral infections.
Messenger RNA (mRNA): mRNA-based therapeutics work by delivering synthetic mRNA molecules into cells, instructing them to produce therapeutic proteins. mRNA vaccines, such as the mRNA COVID-19 vaccines developed by Pfizer-BioNTech and Moderna, have demonstrated the potential of this technology.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/546
Market Segmentation:
Product Type:
RNA Interference (RNAi) Therapeutics: This segment includes RNAi-based drugs that use small interfering RNA (siRNA) molecules to target and silence specific disease-causing genes.
Messenger RNA (mRNA) Therapeutics: This segment includes mRNA-based drugs that deliver synthetic mRNA molecules to instruct cells to produce therapeutic proteins.
Therapeutic Application:
Oncology: RNA-based therapeutics have shown promise in the treatment of various types of cancer by targeting specific oncogenes or inhibiting tumor growth pathways.
Infectious Diseases: RNA-based therapeutics can be used to combat viral infections by targeting viral genes or interfering with the replication process.
Genetic Disorders: RNA-based therapeutics hold potential for treating genetic disorders by targeting and correcting disease-causing genetic mutations.
Cardiovascular Disorders: RNA-based therapeutics may be employed to modulate gene expression and address cardiovascular diseases, such as high cholesterol or heart failure.
Neurological Disorders: RNA-based therapies can target specific genes involved in neurological disorders, including neurodegenerative diseases like Alzheimer's and Parkinson's.
Route of Administration:
Systemic Delivery: Therapeutics administered systemically, such as intravenous (IV) infusion, allow the RNA-based drugs to circulate throughout the body.
Local Delivery: Some RNA-based therapeutics may be delivered directly to a specific target site or organ, such as intratumoral injections for cancer treatment.
Geography:
The market can also be segmented based on geographic regions, such as North America, Europe, Asia-Pacific, and Rest of the World, as each region may have variations in regulatory frameworks, healthcare infrastructure, and market dynamics.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/546
Competitive Landscape:
Alnylam Pharmaceuticals
Moderna Therapeutics
BioNTech SE
Arrowhead Pharmaceuticals
Ionis Pharmaceuticals
Translate Bio
Regulus Therapeutics
Dicerna Pharmaceuticals
Arbutus Biopharma
Quark Pharmaceuticals
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/546
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Browse more latest healthcare reports:
Microfluidic Devices Market https://www.alliedmarketresearch.com/microfluidic-devices-market-A17085
Nucleic Acid Therapeutics Market https://www.alliedmarketresearch.com/nucleic-acid-therapeutics-market-A17089
Angiography Devices Market https://www.alliedmarketresearch.com/Angiography-devices-market
Exosome Diagnostic and Therapeutic Market https://www.alliedmarketresearch.com/exosome-diagnostic-and-therapeutic-market
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Based Therapeutic Market Update 2023: Projected to Cross Market Value of USD 25.12 Billion by 2030 here
News-ID: 3077667 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
